Besse B - Search Results

1

Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung Cancer.

Kas B, Talbot H, Ferrara R, Richard C, Lamarque JP, Pitre-Champagnat S, Planchard D, Balleyguier C, Besse B, Mezquita L, Lassau N, Caramella C. Kas B, et al. Among authors: besse b. JAMA Oncol. 2020 Jul 1;6(7):1039-1046. doi: 10.1001/jamaoncol.2020.1634. JAMA Oncol. 2020. PMID: 32525513 Free PMC article.

2

[Neoadjuvant chemotherapy in non small cell lung cancer].

Besse B, Vignot S, Le Chevalier T. Besse B, et al. Bull Cancer. 2006 Nov;93(11):1087-92. Bull Cancer. 2006. PMID: 17145577 Free article. Review. French.

3

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].

Italiano A, Besse B, Planchard D, Soria JC. Italiano A, et al. Among authors: besse b. Bull Cancer. 2007;94(7 Suppl):F177-88. Bull Cancer. 2007. PMID: 17964994 Review. French.

4

[Angiogenesis targeting in lung cancers].

Planchard D, Besse B. Planchard D, et al. Among authors: besse b. Bull Cancer. 2007;94(7 Suppl):F217-22. Bull Cancer. 2007. PMID: 17964999 Review. French.

5

Leptomeningeal and medullary response to second-line erlotinib in lung adenocarcinoma.

Wagner M, Besse B, Balleyguier C, Soria JC. Wagner M, et al. Among authors: besse b. J Thorac Oncol. 2008 Jun;3(6):677-9. doi: 10.1097/JTO.0b013e3181757a8b. J Thorac Oncol. 2008. PMID: 18520813 Free article. No abstract available.

6

Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers.

Mountzios G, Planchard D, Besse B, Validire P, Girard P, Devisme C, Dimopoulos MA, Soria JC, Fouret P. Mountzios G, et al. Among authors: besse b. Clin Cancer Res. 2008 Jul 1;14(13):4096-102. doi: 10.1158/1078-0432.CCR-07-4150. Clin Cancer Res. 2008. PMID: 18593986

7

[Towards customized therapy for non small cell lung cancer].

Planchard D, Besse B. Planchard D, et al. Among authors: besse b. Bull Cancer. 2008 Oct;95(10):951-8. doi: 10.1684/bdc.2008.0719. Bull Cancer. 2008. PMID: 19004725 French.

8

Adjuvant or induction cisplatin-based chemotherapy for operable lung cancer.

Besse B, Le Chevalier T. Besse B, et al. Oncology (Williston Park). 2009 May;23(6):520-7. Oncology (Williston Park). 2009. PMID: 19544693 Review.

9

Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.

Gomez-Roca C, Raynaud CM, Penault-Llorca F, Mercier O, Commo F, Morat L, Sabatier L, Dartevelle P, Taranchon E, Besse B, Validire P, Italiano A, Soria JC. Gomez-Roca C, et al. Among authors: besse b. J Thorac Oncol. 2009 Oct;4(10):1212-20. doi: 10.1097/JTO.0b013e3181b44321. J Thorac Oncol. 2009. PMID: 19687761 Free article.

10

Use of adjuvant chemotherapy in non-small cell lung cancer in routine practice.

Massard C, Tran Ba Loc P, Haddad V, Pignon JP, Girard P, Monnet I, Trédaniel J, Besse B, Soria JC. Massard C, et al. Among authors: besse b. J Thorac Oncol. 2009 Dec;4(12):1504-10. doi: 10.1097/JTO.0b013e3181bbf1c9. J Thorac Oncol. 2009. PMID: 19745763 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters